Skip to main content
Top

04-05-2024 | Nutrition | Original Contribution

Coffee consumption might be associated with lower potential risk and severity of metabolic syndrome: national health and nutrition examination survey 2003–2018

Authors: He Zhao, Shuolin Wang, Yingdong Han, Menghui Yao, Yun Zhang, Xuejun Zeng

Published in: European Journal of Nutrition

Login to get access

Abstract

Background

Metabolic syndrome (MetS) is a clinical syndrome characterized by multiple metabolic disorders and is a serious global health problem. The coffee effect, acting as one of the most prevalent beverages on metabolic syndrome, is debatable.

Methods

We included patients from the National Health and Nutrition Examination Survey 2003–2018 and used a comprehensive evaluation called the MetS z-score to assess the severity of metabolic syndrome. The relationship between coffee, decaffeinated coffee, tea, and MetS z-scores was explored using a weighted linear regression. We also divided the participants into metabolic and non-metabolic syndrome groups according to the NCEP/ATP III criteria for the subgroup analysis.

Results

A total of 14,504 participants were included in this study. The results demonstrated that drinking more than three cups of coffee daily was significantly linked to lower MetS z-scores (p < 0.001). Daily coffee consumption was also associated with lower BMI (p = 0.02), systolic blood pressure (p < 0.001), Homeostatic Model Assessment for Insulin Resistance (p < 0.001), and triglycerides (p < 0.001), while it was positively correlated with HDL-C (p = 0.001). Participants who consumed more than three cups of coffee daily had a lower MetS z-score in the MetS (p < 0.001) and non-MetS (p = 0.04) groups.

Conclusion

This research indicates that coffee consumption is linked to MetS severity. However, decaffeinated coffee and tea intake were unrelated to MetS severity.
Appendix
Available only for authorised users
Literature
26.
go back to reference Grosso G, Micek A, Godos J, Pajak A, Sciacca S, Bes-Rastrollo M, Galvano F, Martinez-Gonzalez MA (2017) Long-term coffee consumption is Associated with decreased incidence of New-Onset Hypertension: a dose-response Meta-analysis. Nutrients 9(8). https://doi.org/10.3390/nu9080890 Grosso G, Micek A, Godos J, Pajak A, Sciacca S, Bes-Rastrollo M, Galvano F, Martinez-Gonzalez MA (2017) Long-term coffee consumption is Associated with decreased incidence of New-Onset Hypertension: a dose-response Meta-analysis. Nutrients 9(8). https://​doi.​org/​10.​3390/​nu9080890
28.
go back to reference Cicero AFG, Fogacci F, D’Addato S, Grandi E, Rizzoli E, Borghi C, Study obotBH (2023) Self-reported Coffee Consumption and Central and Peripheral Blood pressure in the cohort of the Brisighella Heart Study. Nutrients 15(2):312CrossRefPubMedPubMedCentral Cicero AFG, Fogacci F, D’Addato S, Grandi E, Rizzoli E, Borghi C, Study obotBH (2023) Self-reported Coffee Consumption and Central and Peripheral Blood pressure in the cohort of the Brisighella Heart Study. Nutrients 15(2):312CrossRefPubMedPubMedCentral
35.
go back to reference Wahrburg U, Martin H, Schulte H, Walek T, Assmann G (1994) Effects of two kinds of decaffeinated coffee on serum lipid profiles in healthy young adults. Eur J Clin Nutr 48(3):172–179PubMed Wahrburg U, Martin H, Schulte H, Walek T, Assmann G (1994) Effects of two kinds of decaffeinated coffee on serum lipid profiles in healthy young adults. Eur J Clin Nutr 48(3):172–179PubMed
36.
go back to reference Whayne TF Jr (2015) Coffee: a selected overview of Beneficial or Harmful effects on the Cardiovascular System? Curr Vasc Pharmacol 13(5):637–648CrossRefPubMed Whayne TF Jr (2015) Coffee: a selected overview of Beneficial or Harmful effects on the Cardiovascular System? Curr Vasc Pharmacol 13(5):637–648CrossRefPubMed
Metadata
Title
Coffee consumption might be associated with lower potential risk and severity of metabolic syndrome: national health and nutrition examination survey 2003–2018
Authors
He Zhao
Shuolin Wang
Yingdong Han
Menghui Yao
Yun Zhang
Xuejun Zeng
Publication date
04-05-2024
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-024-03367-1
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare